JC

Jung Choi

CEO

Alterome Therapeutics

Therapeutic Areas

Alterome Therapeutics Pipeline

DrugIndicationPhase
ALTA-2618AKT E17K-driven cancersPhase 1
ALTA-3263KRAS-driven cancersPhase 1